Market Access

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

https://pharmaphorum.com/news/lilly-boehringer-bag-fda-okay-for-diabetes-triple-trijardy-xr/

NICE rejects J&J’s Spravato for treatment-resistant depression

https://pharmaphorum.com/news/nice-rejects-jjs-spravato-for-treatment-resistant-depression/

Drug product formulation and control strategies discussed at PFS East Coast

https://pharmaphorum.com/partner-content/drug-product-formulation-and-control-strategies-discussed-at-pfs-east-coast/

Roche files Tecentriq, Avastin combo as a liver cancer therapy

https://pharmaphorum.com/news/roche-files-tecentriq-avastin-combo-as-a-liver-cancer-therapy/

Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema

https://pharmaphorum.com/news/sanofis-dupixent-funded-in-wales-and-scotland-for-adolescents-with-eczema/

Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US

https://pharmaphorum.com/news/pfizer-launches-biosimilars-to-roches-big-three-cancer-drugs-in-us/

Pre-Filled Syringes East Coast to discuss Digital Connectivity in the PFS Industry

https://pharmaphorum.com/partner-content/pre-filled-syringes-east-coast-to-discuss-digital-connectivity-in-the-pfs-industry/

Bayer gets Japanese approval for prostate cancer drug Nubeqa

https://pharmaphorum.com/news/bayer-gets-japanese-approval-for-prostate-cancer-drug-nubeqa/

NHS patients denied new lung cancer drug after another NICE deadlock

https://pharmaphorum.com/news/nice-deadlock/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search